Post

New research · Dermatology
The Australasian journal of dermatology · 1w
AI / informaticsThe Australasian journal of dermatology · 2026

Patient Acceptability, Perceptions and Concerns Regarding Artificial Intelligence Scribes in Outpatient Dermatology Clinics.

Vanessa Tran, Lachlan D W Lau, Senhong Lee … Celestine C Wong
Read paper
DermatologyAI / informatics

Most dermatology patients reported comfort with artificial intelligence scribes in clinic

Patient Acceptability, Perceptions and Concerns Regarding Artificial Intelligence Scribes in Outpatient Dermatology Clinics.

Vanessa Tran … Celestine C Wong
The Australasian journal of dermatology · 2026
Methods

This cross-sectional survey assessed patient acceptability, perceptions and concerns regarding ambient artificial intelligence (artificial intelligence) scribes in an outpatient dermatology clinic.

Results
82.1%
patients who said they felt comfortable with an artificial intelligence note-taking tool during visits
“
Conclusion

These findings highlight the need for transparent, patient-centred implementation strategies and tailored discussions addressing patient concerns.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
70.8%
clinical improvement was seen in far more terbinafine-treated nails than fluconazole-treated ones
Cohort Study
HR 1.06
6% higher rate of non-melanoma skin cancer with GLP-1 drugs versus SGLT2 inhibitors; effect faded after bias correction.
Cohort Study
> 1100 differentially expressed genes
genes show different activity levels in atopic dermatitis skin compared to healthy skin
Randomized Trial
odds ratio for cure, 0.64
higher-dose ivermectin meant lower odds of curing severe scabies
Study
95.9%
Fairness across demographic groups improved 95.9% for skin images, accuracy maintained
AI / Informatics
0.954
how well the AI told nail melanoma (a nail cancer) from harmless nail pigment - higher is better
Cohort Study
48%
nearly half never started treatment their surgeon recommended
Study
0.65
converts standard dose planning to match this therapy - lower means a smaller adjusted dose